In cervical cancer, Li (2020) verified that MIR31HG silencing inhibited cervical cancer cell proliferation and invasion, whereas anti-miR-361-3p or overexpression of epithelial membrane protein 1 (EMP1) led to the opposite effect. Here, EMP1 is linked to cervical carcinoma.